ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,730Medicare Part D Prescriptions Filled, Including Refills

Rank: 921 out of 2343

$447K Total Retail Price of All Prescriptions

Rank: 796 out of 2343

262 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 262 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 262 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 5,665 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 298 249 1 3
SIMVASTATIN 213 166 2 1
AMLODIPINE BESYLATE 211 185 3 5
OMEPRAZOLE 206 179 4 4
LEVOTHYROXINE SODIUM 175 144 5 2
NAMENDA 169 166 6 36
ATORVASTATIN CALCIUM 165 155 7 10
METOPROLOL SUCCINATE 137 132 8 14
FUROSEMIDE 129 125 9 6
METFORMIN HCL 114 83 10 9
DONEPEZIL HCL 109 109 11 21
JANTOVEN 95 92 12 81
METOPROLOL TARTRATE 87 77 13 7
CITALOPRAM HBR 85 65 14 17
PRAVASTATIN SODIUM 81 68 15 15
ESCITALOPRAM OXALATE 77 73 16 55
PANTOPRAZOLE SODIUM 76 63 17 22
GABAPENTIN 76 60 17 16
POLYETHYLENE GLYCOL 3350 73 70 19 54
WARFARIN SODIUM 70 70 20 8
LOSARTAN POTASSIUM 67 39 21 19
ZOLPIDEM TARTRATE 67 61 21 24
HYDROCODONE-ACETAMINOPHEN 63 49 S3 23 13
AZITHROMYCIN 60 46 24 39
LIDODERM 60 60 24 130
ALLOPURINOL 59 59 26 31
MELOXICAM 57 52 27 68
CELEBREX 57 43 27 71
CEFDINIR 56 48 29 480
KLOR-CON M20 56 51 29 44
ATENOLOL 56 55 29 12
PAROXETINE HCL 56 42 29 66
CYCLOBENZAPRINE HCL 55 39 R 33 109
POTASSIUM CHLORIDE 52 33 34 18
PREDNISONE 52 47 34 37
SERTRALINE HCL 51 51 36 20
CRESTOR 51 42 36 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.